Health Care & Life Sciences » Pharmaceuticals | BioDelivery Sciences International Inc.

BioDelivery Sciences International Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
23,175.80
70,472.00
83,560.00
32,019.00
21,195.00
43,822
Total Accounts Receivable
2,794.00
3,141.00
2,488.00
2,967.00
8,852.00
13,627
Inventories
-
1,828.00
2,558.00
3,368.00
6,091.00
5,406
Other Current Assets
630.70
2,182.00
2,233.00
2,436.00
3,610.00
3,188
Total Current Assets
26,600.50
77,623.00
90,839.00
40,790.00
39,748.00
66,043
Net Property, Plant & Equipment
178.20
3,890.00
4,262.00
4,230.00
3,778.00
3,072
Intangible Assets
7,911.50
6,941.00
5,971.00
5,000.00
44,575.00
39,418
Other Assets
3,315.30
857.00
1,700.00
1,700.00
-
-
Total Assets
38,005.40
89,311.00
102,772.00
51,720.00
88,101.00
108,533
ST Debt & Current Portion LT Debt
7,333.30
8,000.00
6,707.00
-
-
Accounts Payable
10,416.00
9,072.00
10,177.00
9,397.00
12,236.00
Other Current Liabilities
7,242.30
12,129.00
11,199.00
9,891.00
13,913.00
Total Current Liabilities
24,991.60
29,201.00
28,083.00
19,288.00
26,149.00
Long-Term Debt
11,844.70
4,173.00
22,168.00
29,272.00
47,660.00
Other Liabilities
1,981.50
1,541.00
20,825.00
20,825.00
5,415.00
Total Liabilities
38,817.80
34,915.00
71,076.00
69,385.00
79,224.00
Common Equity (Total)
815.10
54,394.00
31,694.00
17,667.00
8,875.00
Total Shareholders' Equity
812.40
54,396.00
31,696.00
17,665.00
8,877.00
Total Equity
812.40
54,396.00
31,696.00
17,665.00
8,877.00
Liabilities & Shareholders' Equity
38,005.40
89,311.00
102,772.00
51,720.00
88,101.00
Preferred Stock (Carrying Value)
2.70
2.00
2.00
2.00
2.00

About BioDelivery Sciences International

View Profile
Address
4131 ParkLake Avenue
Raleigh North Carolina 27612
United States
Employees -
Website http://www.bdsi.com
Updated 07/08/2019
BioDelivery Sciences International, Inc. is a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.